The effects of FPC2‐IG‐IL‐2 on tumor‐infiltrating immune cell populations were examined by the immune monitoring of CT26‐bearing mice with intratumorally injected PBS, FPC2‐IG, FPC2‐IG‐IL‐2, and free IL‐2. This evidence concerns the gene IL2 and neoplasm.